Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ramey

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in <i>NEFL</i>Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2025
Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFLPoorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Journal of Neuroscience Methods|June 25, 2021
Development of a protocol to assess within-subject, regional white matter hyperintensity changes in aging and dementiaAhmed A Bahrani, Charles D Smith, Justin M Barber, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2024
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity ConferenceCourtney M Kloske, Simin Mahinrad, Christopher J Barnum, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in <i>NEFL</i>Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2025
Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFLPoorvi H Dua, Bazilco M J Simon, Chiara B E Marley, et al.
Journal of Neuroscience Methods|June 25, 2021
Development of a protocol to assess within-subject, regional white matter hyperintensity changes in aging and dementiaAhmed A Bahrani, Charles D Smith, Justin M Barber, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2024
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity ConferenceCourtney M Kloske, Simin Mahinrad, Christopher J Barnum, et al.
Pageof 5